Top Atopic Dermatitis Research Leaders (KOLs) 2021-2026

Top research leaders (by recent publication volume)

#	Researcher	Affiliation	Papers
1	Eyerich Kilian	University of Freiburg	8
2	Napolitano Maddalena	University of Naples Federico II	8
3	Patruno Cataldo	University Magna Graecia of Catanzaro	7
4	Peris Ketty	Dipartimento Universitario di Medicina e Chirurgia Traslaz	6
5	Ortoncelli Michela	University of Turin	6
6	Torres Tiago	University of Porto	5
7	de Bruin-Weller Marjolein	University Medical Center Utrecht	5
8	Gori Niccolò	Dipartimento Universitario di Medicina e Chirurgia Traslaz	5
9	Balato Anna	University of Campania Luigi Vanvitelli	5
10	Ribero Simone	University of Turin	5
11	Marzano Angelo Valerio	Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	5
12	Ferrucci Silvia Mariel	Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	5
13	Chiricozzi Andrea	Dipartimento Universitario di Medicina e Chirurgia Traslaz	5
14	Wollenberg Andreas	Augsburg University Hospital	5
15	Bieber Thomas	Medicine Campus Davos	5
16	Costanzo Antonio	Humanitas University	5
17	Blauvelt Andrew	Oregon Medical Research Center	4
18	Yeung Jensen	University of Toronto	4

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

University of Toronto (15), Northwestern University Feinberg School of Medicine (11), University Medical Center Utrecht (10), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (8), McMaster University (8), University of Naples Federico II (7), The George Washington University School of Medicine and He (7), College of Medicine (7), University of Freiburg (6), University of Campania Luigi Vanvitelli (6)

Active subtopics

Dermatitis, Atopic (163), Antibodies, Monoclonal, Humanized (88), Treatment Outcome (76), Janus Kinase Inhibitors (74), Severity of Illness Index (58), Heterocyclic Compounds, 3-Ring (55), Sulfonamides (39), Pyrimidines (37), Dermatologic Agents (34)

Top journals

Journal of the European Academy of Dermatology and Venereology : JEADV (15), Dermatology and therapy (13), Journal of the American Academy of Dermatology (11), Dermatitis : contact, atopic, occupational, drug (10), The Journal of dermatological treatment (9), Clinical and experimental dermatology (7)

Representative recent papers

Efficacy and safety of dupilumab following discontinuation of JAK inhibitors in patients with moderate-to-severe atopic dermatitis (2026) · PMID 42459641

Janus kinase inhibitors enhance the efficacy of dupilumab in refractory atopic dermatitis. (2026) · PMID 42394502

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions. (2026) · PMID 42329514

Comparative pharmacovigilance of herpetic infections with dupilumab and JAK inhibitors in atopic dermatitis. (2026) · PMID 42252930

Time-Varying Acne Risk After Upadacitinib Initiation in Atopic Dermatitis: A New-User, Active-Comparator Retrospective Study. (2026) · PMID 42231096

Want the full cited brief?

A full Atopic Dermatitis brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us